Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00958399 · ClinicalTrials.gov registry record · NA

Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT00958399 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00958399, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Research suggests dietary fiber may play a role in weight management, and fiber consumption is inversely associated with body weight, body fat, and BMI in cross-sectional studies. These effects may be mediated by increased satiety, reduced food intake, or changes in blood levels of glucose, insulin, and gut hormones. The purpose of this study is to determine the satiety, glycemic, hormonal, and gastrointestinal responses of novel fiber supplements.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Resistant Starch
  • DIETARY_SUPPLEMENT Resistant starch + soluble fiber
  • DIETARY_SUPPLEMENT Fiber made from corn starch
  • DIETARY_SUPPLEMENT Fiber made from corn starch + soluble fiber

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2008-07
Est. Completion 2010-04
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT00958399

The ClinicalTrials.gov registry entry for NCT00958399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.

NCT00958399 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00958399 about?

NCT00958399 is a clinical study titled "Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers". Research suggests dietary fiber may play a role in weight management, and fiber consumption is inversely associated with body weight, body fat, and BMI in cross-sectional studies. These effects may be mediated by increased satiety, reduced food intake, or changes in blood levels of glucose, insulin,...

What is the current status of trial NCT00958399?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-07. Estimated completion is 2010-04.

What interventions are being tested in trial NCT00958399?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Resistant Starch (DIETARY_SUPPLEMENT), Resistant starch + soluble fiber (DIETARY_SUPPLEMENT), Fiber made from corn starch (DIETARY_SUPPLEMENT), Fiber made from corn starch + soluble fiber (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00958399?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.